EATRIS is spearheading a major initiative under the PRECISEU project to map the capacities for developing and delivering Advanced Therapy Medicinal Products (ATMPs) across Europe. This strategic effort is set to play a critical role in improving patient access, accelerating clinical development, and building a more cohesive and innovative European ATMP ecosystem.
As ATMPs, in particular cell and gene therapies, rapidly move from the lab to the clinic, Europe’s ability to support their development and equitable delivery depends on understanding where expertise, infrastructure, and readiness exist. The EATRIS-led mapping survey addresses this need by assessing academic centers, GMP and Pre-GMP manufacturing sites, clinical trial hubs, and regulatory support amongst other critical capacities in ATMP translation throughout Europe.
“This mapping is about more than infrastructure, it’s about empowering Europe to deliver cutting-edge therapies to patients, no matter where they live,” said Dr. David Morrow, Senior Scientific Programme Manager for ATMPs at EATRIS.
The initiative will provide a comprehensive overview of Europe’s ATMP landscape, supporting:
- Smarter investment in under-resourced regions
- Faster regulatory approvals and clinical trial deployment
- Cross-border collaboration and knowledge sharing, including the standardisation of ATMP manufacturing workflows, leading to more cost-effective development
- Enhanced synergies between academia, industry, and healthcare providers
By leveraging its pan-European network, EATRIS ensures this mapping initiative is robust, inclusive, and aligned with real-world needs. Through PRECISEU, the project and its innovation regions seek to advance ATMP development and increase patient access. This initiative will not only highlight existing capacities but also guide future capacity-building and strategic development efforts.
Ultimately, this work will lay the foundation for a more connected, equitable, and innovation-ready Europe where patients can benefit from the promise of advanced therapies regardless of location.
Fill in the survey and get on the map here.
